Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q95Z86
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 7 |
GO:0006793 | phosphorus metabolic process | 3 | 7 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 7 |
GO:0016311 | dephosphorylation | 5 | 7 |
GO:0019538 | protein metabolic process | 3 | 7 |
GO:0036211 | protein modification process | 4 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0043412 | macromolecule modification | 4 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 7 |
GO:0004725 | protein tyrosine phosphatase activity | 4 | 5 |
GO:0008138 | protein tyrosine/serine/threonine phosphatase activity | 4 | 7 |
GO:0016787 | hydrolase activity | 2 | 7 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 7 |
GO:0016791 | phosphatase activity | 5 | 7 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 7 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.376 |
CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.376 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.376 |
DEG_COP1_1 | 7 | 15 | PF00400 | 0.437 |
DEG_MDM2_SWIB_1 | 166 | 173 | PF02201 | 0.544 |
DEG_SCF_FBW7_1 | 171 | 178 | PF00400 | 0.567 |
DEG_SPOP_SBC_1 | 248 | 252 | PF00917 | 0.593 |
DOC_CYCLIN_yCln2_LP_2 | 162 | 168 | PF00134 | 0.531 |
DOC_MAPK_DCC_7 | 161 | 169 | PF00069 | 0.345 |
DOC_MAPK_DCC_7 | 8 | 17 | PF00069 | 0.437 |
DOC_MAPK_gen_1 | 42 | 49 | PF00069 | 0.581 |
DOC_MAPK_MEF2A_6 | 161 | 169 | PF00069 | 0.345 |
DOC_MAPK_MEF2A_6 | 8 | 17 | PF00069 | 0.437 |
DOC_PP2B_LxvP_1 | 162 | 165 | PF13499 | 0.541 |
DOC_PP2B_LxvP_1 | 198 | 201 | PF13499 | 0.556 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.684 |
DOC_USP7_MATH_1 | 221 | 225 | PF00917 | 0.605 |
DOC_USP7_MATH_1 | 268 | 272 | PF00917 | 0.793 |
DOC_USP7_MATH_1 | 273 | 277 | PF00917 | 0.710 |
DOC_USP7_UBL2_3 | 203 | 207 | PF12436 | 0.681 |
DOC_WW_Pin1_4 | 160 | 165 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.378 |
DOC_WW_Pin1_4 | 291 | 296 | PF00397 | 0.606 |
LIG_14-3-3_CanoR_1 | 139 | 147 | PF00244 | 0.576 |
LIG_14-3-3_CanoR_1 | 176 | 180 | PF00244 | 0.552 |
LIG_APCC_ABBA_1 | 131 | 136 | PF00400 | 0.576 |
LIG_BRCT_BRCA1_1 | 13 | 17 | PF00533 | 0.440 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.492 |
LIG_FHA_1 | 172 | 178 | PF00498 | 0.442 |
LIG_FHA_1 | 244 | 250 | PF00498 | 0.604 |
LIG_FHA_1 | 97 | 103 | PF00498 | 0.576 |
LIG_LIR_Apic_2 | 45 | 51 | PF02991 | 0.505 |
LIG_LIR_Gen_1 | 14 | 25 | PF02991 | 0.565 |
LIG_LIR_Gen_1 | 149 | 160 | PF02991 | 0.563 |
LIG_LIR_Gen_1 | 163 | 173 | PF02991 | 0.430 |
LIG_LIR_Gen_1 | 79 | 89 | PF02991 | 0.492 |
LIG_LIR_Nem_3 | 132 | 137 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.592 |
LIG_LIR_Nem_3 | 149 | 155 | PF02991 | 0.501 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 79 | 84 | PF02991 | 0.492 |
LIG_Pex14_2 | 166 | 170 | PF04695 | 0.532 |
LIG_SH2_CRK | 156 | 160 | PF00017 | 0.540 |
LIG_SH2_CRK | 196 | 200 | PF00017 | 0.599 |
LIG_SH2_CRK | 35 | 39 | PF00017 | 0.530 |
LIG_SH2_PTP2 | 152 | 155 | PF00017 | 0.492 |
LIG_SH2_SRC | 54 | 57 | PF00017 | 0.576 |
LIG_SH2_STAP1 | 196 | 200 | PF00017 | 0.535 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.572 |
LIG_SH2_STAT5 | 48 | 51 | PF00017 | 0.499 |
LIG_SH3_3 | 262 | 268 | PF00018 | 0.725 |
LIG_SH3_3 | 7 | 13 | PF00018 | 0.492 |
LIG_SH3_3 | 81 | 87 | PF00018 | 0.433 |
LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.492 |
LIG_SUMO_SIM_par_1 | 245 | 252 | PF11976 | 0.556 |
LIG_TYR_ITIM | 194 | 199 | PF00017 | 0.599 |
MOD_CDK_SPK_2 | 171 | 176 | PF00069 | 0.574 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.492 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.786 |
MOD_CK1_1 | 252 | 258 | PF00069 | 0.703 |
MOD_CK1_1 | 271 | 277 | PF00069 | 0.654 |
MOD_CK1_1 | 280 | 286 | PF00069 | 0.642 |
MOD_CK2_1 | 129 | 135 | PF00069 | 0.576 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.609 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.592 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.622 |
MOD_GlcNHglycan | 251 | 254 | PF01048 | 0.652 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.310 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.806 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.698 |
MOD_GlcNHglycan | 279 | 282 | PF01048 | 0.642 |
MOD_GlcNHglycan | 4 | 7 | PF01048 | 0.593 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.287 |
MOD_GSK3_1 | 11 | 18 | PF00069 | 0.565 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.460 |
MOD_GSK3_1 | 208 | 215 | PF00069 | 0.636 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.531 |
MOD_GSK3_1 | 24 | 31 | PF00069 | 0.492 |
MOD_GSK3_1 | 243 | 250 | PF00069 | 0.659 |
MOD_GSK3_1 | 263 | 270 | PF00069 | 0.802 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.714 |
MOD_GSK3_1 | 280 | 287 | PF00069 | 0.611 |
MOD_N-GLC_1 | 15 | 20 | PF02516 | 0.365 |
MOD_N-GLC_1 | 207 | 212 | PF02516 | 0.689 |
MOD_N-GLC_1 | 33 | 38 | PF02516 | 0.353 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.528 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.459 |
MOD_NEK2_1 | 288 | 293 | PF00069 | 0.562 |
MOD_PIKK_1 | 263 | 269 | PF00454 | 0.764 |
MOD_PK_1 | 42 | 48 | PF00069 | 0.492 |
MOD_PKA_2 | 175 | 181 | PF00069 | 0.578 |
MOD_Plk_1 | 15 | 21 | PF00069 | 0.565 |
MOD_Plk_1 | 33 | 39 | PF00069 | 0.562 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.572 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.423 |
MOD_Plk_4 | 175 | 181 | PF00069 | 0.482 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.461 |
MOD_Plk_4 | 284 | 290 | PF00069 | 0.735 |
MOD_Plk_4 | 33 | 39 | PF00069 | 0.517 |
MOD_ProDKin_1 | 160 | 166 | PF00069 | 0.497 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.370 |
MOD_ProDKin_1 | 291 | 297 | PF00069 | 0.606 |
MOD_SUMO_rev_2 | 132 | 140 | PF00179 | 0.576 |
TRG_DiLeu_BaLyEn_6 | 100 | 105 | PF01217 | 0.576 |
TRG_ENDOCYTIC_2 | 137 | 140 | PF00928 | 0.492 |
TRG_ENDOCYTIC_2 | 152 | 155 | PF00928 | 0.527 |
TRG_ENDOCYTIC_2 | 156 | 159 | PF00928 | 0.626 |
TRG_ENDOCYTIC_2 | 196 | 199 | PF00928 | 0.594 |
TRG_ENDOCYTIC_2 | 35 | 38 | PF00928 | 0.530 |
TRG_ER_diArg_1 | 41 | 44 | PF00400 | 0.576 |
TRG_Pf-PMV_PEXEL_1 | 184 | 188 | PF00026 | 0.567 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JUF6 | Bodo saltans | 62% | 97% |
A0A3S5H5B2 | Leishmania donovani | 92% | 97% |
A4H3X6 | Leishmania braziliensis | 79% | 100% |
A4HS51 | Leishmania infantum | 92% | 97% |
E9AK38 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |